Results for tag: "Zurcal"

The Zurcal market is a segment of the Gastrointestinal Drugs market, which includes drugs used to treat conditions of the digestive system. These drugs are used to treat a variety of conditions, including irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. The Zurcal market is composed of both prescription and over-the-counter medications, as well as dietary supplements. The market is highly competitive, with a wide range of products available from both large and small companies. Some of the major companies in the Zurcal market include AstraZeneca, GlaxoSmithKline, Pfizer, Merck, and Novartis. Other companies include AbbVie, Allergan, Amgen, Bristol-Myers Squibb, and Eli Lilly. These companies offer a variety of products, ranging from prescription medications to over-the-counter medications and dietary supplements. Show Less Read more